PAZOFOS: Phase Ib and Phase II Trial of Pazopanib +/- Fosbretabulin in Advanced Recurrent Ovarian Cancer
Clinical trial NCT02055690 · TERMINATED
Trial details
- NCT number
- NCT02055690
- Sponsor
- The Christie NHS Foundation Trust
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-01
- Primary completion
- 2017-11-24
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.